Oxford
Branch
Branch
Select your branch
Finance for Scientists and Pitfalls of Entrepreneurship – Lecture
Description
"An investment in knowledge pays the best interest"
Benjamin Franklin
Scientists and up-and-coming entrepreneurs are not financial experts. However, to have a successful business you need to navigate through the basics of finance for your investment to flourish. Join us on Wednesday 8th of March 2017 to hear from Sue Staunton, Partner and Head of Technology at James Cowper Kreston LLP, who will share her expertise on early financial planning in the life-tech industry, and help you:
- Understand the key terms and basic financial principles
- Manage cash flow, and forecast the business
- Identify types of funding available to early-stage ventures
- Realise when and who best to ask for financial advice
- Identify crucial financial issues that you need to be aware of and watch out for
Sharing the platform with Sue is Professor Steven Zimmer, Founder and CEO of MitoDys Therapeutics. Prof Zimmer has a long history of advising and investing in life-science based ventures and will share his insights about the pitfalls of entrepreneurship.
After the seminar there will be an opportunity for networking, so whether you have an interest in innovation, possess skills or advice to offer to startups or are an establihed entrepreneur, we look forward to seeing you for what promises to be a fantastic evening.
This session is part of a series on entrepreneurship in health and life-sciences organised by Innovation Forum Oxford, in collaboration with the MRC Weatherall Institute of Molecular Medicine.
This lecture series is a part of the IMAGINE IF! accelerator programme, designed to inspire and foster grassroots innovation. The business idea competition provides support, mentorship and opportunity to secure $30,000 of non-diluted capital.
Note: If you are already registered for the complete lecture series there is no need to register again for this event. Please send any booking queries to [email protected].
Schedule
17:30-18:00
Registration
18:00-18:50
Finance for scientists – Sue Staunton
18:50-19:30
Pitfalls and inevitable failures in entrepreneurship – Professor Steven Zimmer
19:30-21:30
Networking
Speakers
Sue Staunton is a business services partner for accountants and business advisers, James Cowper Kreston, based in their Oxford office. Sue heads the firm's technology team which advises clients of all sizes from spin out to IPO and beyond.
Sue works with clients on the development and implementation of their corporate strategies. She also has a great deal of experience in working with businesses in financial crisis to establish strategies to assist them to move forward successfully.
Sue has been involved in running a number of businesses so understands what it can be like at the sharp end!
James Cowper Kreston is one of the leading firms of accountants and business advisers in the Thames Valley and South of England, with over 200 Partners and staff operating from six offices. The firm has a strong international capability through its membership of Kreston International, the 13th largest accounting association in the World.
Steven Zimmer is the Founder and CEO of MitoDys Therapeutics, an Oxford-based start up company focused on uncovering novel drugs for the treatment of selected neurodegenerative diseases. He also acts as an advisor to several Academic scientists aiming to translate basic discoveries into live commercial realities. He is a trained scientist (Biochemistry and Molecular Biology) and has had a long career in equity research, investment banking, portfolio management and venture capital both in the US and in the UK/Europe (Robert Fleming, DLJ & CSFB). He is also currently a visiting researcher in the Structural Genomics consortium at Oxford University helping out with translational project in epigenetics and rare diseases. As a result of this activity, he has founded EpiCombi Therapeutics, which will develop a drug discovery platform to rationally uncover epigenetics-driven drug combinations for oncology therapeutics. He is also a co-founder of Elpis Therapeutics, a company developing a novel therapy for remyelination in Multiple Sclerosis. In the recent past, he has consulted for UK, US and European Biotech companies (e-Therapeutics plc, Selventa Inc. and Hemarina SA) as a strategic advisor both on business development and financing strategy. He has co-founded several companies, including Steribottle limited, Protein Sciences Inc, Tissuomics and Orthomatrix Inc.
Do you want to sponsor this event? Apply here
Request sponsorship opportunities package
Sponsor this event